All Stories

  1. The Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer Prior to any Systematic Therapy: A Systematic Review
  2. Clinical Evidence on the Magnitude of Change in Growth Pathway Activity in Relation to Tamoxifen Resistance is Required
  3. Stemness Phenotype in Tamoxifen Resistant Breast Cancer Cells may be induced by Interactions between Receptor Tyrosine Kinases and ERα-66
  4. Interaction between MUC1 and tamoxifen resistance in breast cancer